Get the Stockscreener App
3.82
5.22%
-0.21
Bone Biologics Corp stock is traded at $3.82, with a volume of 402.57K.
It is down -5.22% in the last 24 hours and down -27.66% over the past month.
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
See More
Previous Close:
$4.03
Open:
$3.91
24h Volume:
402.57K
Relative Volume:
14.20
Market Cap:
$3.03M
Revenue:
-
Net Income/Loss:
$-4.14M
P/E Ratio:
-0.5268
EPS:
-7.2511
Net Cash Flow:
$-4.79M
1W Performance:
-31.22%
1M Performance:
-27.66%
6M Performance:
-32.29%
1Y Performance:
-46.95%
1-Day Range:
$3.35
$4.00
1-Week Range:
$3.35
$6.19
52-Week Range:
$3.35
$25.50
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
3.8198 | 3.03M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
136.16 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.99 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
398.25 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.44 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.37 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Bone Biologics Corp Stock (BBLG) Latest News
Bone Morphogenetic Protein Market Expected to Hit USD 12.3 Billion by 2032 with a Remarkable 5.03% CAGR - industrytoday.co.uk
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update - Defense World
Bone Biologics (OTC:BBLG) Trading Down 11.7% – Should You Sell? - Defense World
United States shares higher at close of trade; Dow Jones Industrial Average up 0.25% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.25% - Investing.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.25% - Investing.com UK
Bone Biologics (BBLG) Trading Halt Sparks Anticipation | BBLG St - GuruFocus
Bone Biologics announces 1-for-6 reverse stock split By Investing.com - Investing.com South Africa
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split | BB - GuruFocus
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split - GuruFocus
Bone Biologics announces 1-for-6 reverse stock split - Investing.com
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split | BBLG Stock News - GuruFocus
Bone Biologics Announces 1-for-6 Reverse Stock Split - Business Wire
Bone Biologics (NASDAQ:BBLG) Trading Down 2.4% – What’s Next? - Defense World
Bone Biologics shareholders approve key proposals By Investing.com - Investing.com Canada
Bone Biologics shareholders approve key proposals - Investing.com
Global and China Osteoporosis Drugs Market Detailed in New Research ReportAmgen, Eli Lilly - openPR.com
Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews
Bone Biologics (OTC:BBLG) Shares Up 18.5% – Time to Buy? - Defense World
TETROUS®, INC. ANNOUNCES EXPANDED CLINICAL APPLICATIONS OF ENFIX® FOR ENTHESIS REPAIR - Longview News-Journal
(BBLGW) Proactive Strategies - news.stocktradersdaily.com
WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering - Barchart.com
Zacks Small Cap Forecasts Bone Biologics Q2 Earnings - Defense World
Bone Biologics Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Trend Tracker for (BBLGW) - news.stocktradersdaily.com
Orthobiologics Market Grows Strong with Expanding Use in Sports - openPR.com
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics - IT News Online
Revolutionary BMP Super-Agonists: Darnatein's New Biologics Promise Breakthrough in Bone and Cartilage Repair - Stock Titan
Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe - Yahoo Finance
Bone Biologics (OTC:BBLG) Trading Down 0.4% – Should You Sell? - Defense World
BBLG stock touches 52-week low at $0.57 amid market challenges By Investing.com - Investing.com South Africa
BBLG stock touches 52-week low at $0.57 amid market challenges - Investing.com Australia
Orthobiologics Market Set to Witness Significant Growth - openPR.com
Aurobindo Pharma Arm Completes Phase 1 Trials of New Bone Medicine - Equitypandit
When (BBLGW) Moves Investors should Listen - news.stocktradersdaily.com
BBLG stock touches 52-week low at $0.7 amid market challenges - Investing.com Canada
BBLG stock touches 52-week low at $0.7 amid market challenges By Investing.com - Investing.com South Africa
Bone Biologics (OTC:BBLG) Trading 1.9% Higher – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Bone Biologics sets date for 2025 annual meeting - Investing.com
Top Trend In Orthobiologics Devices And Equipment Market 2025: Biodegradable Implants Transforming Orthobio... - WhaTech
Orthobiologics Market Future Business Opportunities - openPR.com
TETROUS®, INC. SIGNS NEW DISTRIBUTION AGREEMENT IN NEW ZEALAND TO EXPAND PRESENCE IN THE ASIA-PACIFIC MARKET AND ADDS DR. CRAIG BALL TO IT'S SURGEON ADVISORY BOARD - PR Newswire
Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors - The Malaysian Reserve
Bone Biologics (OTC:BBLG) Trading 1.2% Higher – Here’s Why - Defense World
MTF Biologics Collaborates with Kolosis BIO to Boost DBX Brand - World Business Outlook
MTF Biologics Expands Partnership with Kolosis BIO to Strengthen DBX Brand - StreetInsider.com
TETROUS®, INC. SUCCESSFULLY CLOSES FINANCING ROUND, SECURING ADDITIONAL CAPITAL FOR FUTURE GROWTH - PR Newswire
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.43%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):